Multiple studies on GLP-1 receptor agonists have documented that approximately 25-40% of total weight lost comes from lean body mass rather than fat
Mechanism of action What sets retatrutide apart is its ability to simultaneously activate three key receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon (GCG) receptor
Comparable to therapy with GLP-1RA, a stepwise dose escalation starting with a low starting dose was associated with a lower rate of gastrointestinal side effects and better tolerability of tirzepatide (67)
We sincerely thank all participants and their caregivers for their meaningful contributions. The class of drugs, derived from the protein in the venom of the Gila monster, a large black lizard with pink-orange markings, has sparked a revolution in the treatment of metabolic disease
Sobo, is required to tailor the medication and complementary protocol (e.g., Peptides, NAD+) to your unique metabolic profile
Martinez-Jimenez, M